Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models

The use of therapeutic neutralizing antibodies against SARS-CoV-2 infection has been highly effective. However, there remain few practical antibodies against viruses that are acquiring mutations. In this study, we created 494 monoclonal antibodies from patients with COVID-19-convalescent, and identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeshita, Masaru, Fukuyama, Hidehiro, Kamada, Katsuhiko, Matsumoto, Takehisa, Makino-Okamura, Chieko, Uchikubo-Kamo, Tomomi, Tomabechi, Yuri, Hanada, Kazuharu, Moriyama, Saya, Takahashi, Yoshimasa, Ishigaki, Hirohito, Nakayama, Misako, Nguyen, Cong Thanh, Kitagawa, Yoshinori, Itoh, Yasushi, Imai, Masaki, Maemura, Tadashi, Furusawa, Yuri, Ueki, Hiroshi, Iwatsuki-Horimoto, Kiyoko, Ito, Mutsumi, Yamayoshi, Seiya, Kawaoka, Yoshihiro, Shirouzu, Mikako, Ishii, Makoto, Saya, Hideyuki, Kondo, Yasushi, Kaneko, Yuko, Suzuki, Katsuya, Fukunaga, Koichi, Takeuchi, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664764/
https://www.ncbi.nlm.nih.gov/pubmed/36406861
http://dx.doi.org/10.1016/j.isci.2022.105596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664764/
https://www.ncbi.nlm.nih.gov/pubmed/36406861
http://dx.doi.org/10.1016/j.isci.2022.105596

Ejemplares similares